DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Stilgenbauer S, Cymbalista F, Leblond V et al.
Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW.
Blood ASH Annual Meeting Abstract 2012;
210
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.